Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic‐clonic seizures: Post hoc analysis of phase III double‐blind and open‐label extension studies

Benzer Materyaller

• Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic‐clonic seizures: Post hoc analysis of Phase II and Phase III double‐blind and open‐label extension studies in India
  Yazar:: Mehndiratta, Man M., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
  Yazar:: Rektor, Ivan, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double‐blind, phase III studies
  Yazar:: Steinhoff, Bernhard J., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures
  Yazar:: Fogarasi, Andras, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: A randomized trial
  Yazar:: French, Jacqueline A., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)